Current options for the prevention and treatment of migraine
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (6) , 772-788
- https://doi.org/10.1016/s0149-2918(01)80069-2
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Comparison of Rizatriptan 10 Mg vs. Zolmitriptan 2.5 Mg in the Acute Treatment of MigraineCephalalgia, 2000
- Rizatriptan in the treatment of migraineClinical Therapeutics, 1999
- Acute Treatment of Migraine Attacks: Efficacy and Safety of A Nonsteroidal Anti-Inflammatory Drug, Diclofenac-Potassium, in Comparison To Oral Sumatriptan and PlaceboCephalalgia, 1999
- Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of MigraineHeadache: The Journal of Head and Face Pain, 1998
- Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in MigraineHeadache: The Journal of Head and Face Pain, 1998
- Migraine Prophylactic DrugsCephalalgia, 1997
- Magnesium in the Prophylaxis of Migraine—a Double-Blind, Placebo-Controlled StudyCephalalgia, 1996
- Randomized, Placebo-Controlled Evaluation of Prochlorperazine Versus Metoclopramide for Emergency Department Treatment of Migraine HeadacheAnnals of Emergency Medicine, 1995
- Intravenous Chlorpromazine vs Intravenous Metoclopramide in Acute Migraine HeadacheAcademic Emergency Medicine, 1995
- RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTIONThe Lancet, 1988